Daniel is a member of the firm’s global generic pharmaceutical industry group and also has over 20 years of experience focused on corporate and securities matters, including M&A, public offerings and financings, and related corporate governance matters.
Daniel Keating is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where his practice primarily focuses on corporate and securities matters, including sophisticated domestic and international transactions. He is also a member of the firm’s global generic pharmaceutical industry group.
Dan has more than 20 years of legal experience. He has represented clients in mergers and acquisitions, public offerings, and financings, as well as related corporate governance matters. In particular, Dan has substantial experience representing multinational companies on cross-border M&A deals and complex commercial transactions. Dan’s clients include companies across a diverse range of industries, including technology, fintech, financial, pharmaceutical, and life sciences.
Prior to joining the firm, Dan was a was a corporate partner in an international law firm based in that firm’s Washington, D.C., office. In this role, he advised on a variety of corporate matters, including representing a pharmaceutical company in the acquisition of numerous product portfolios in dozens of countries worldwide. He also acted as underwriters' counsel for numerous offerings of debt and equity securities.
Daniel Keating is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where his practice primarily focuses on corporate and securities matters, including sophisticated domestic and international transactions. He is also a member of the firm’s global generic pharmaceutical industry group.
Dan has more than 20 years of legal experience. He has represented clients in mergers and acquisitions, public offerings, and financings, as well as related corporate governance matters. In particular, Dan has substantial experience representing multinational companies on cross-border M&A deals and complex commercial transactions. Dan’s clients include companies across a diverse range of industries, including technology, fintech, financial, pharmaceutical, and life sciences.
Prior to joining the firm, Dan was a was a corporate partner in an international law firm based in that firm’s Washington, D.C., office. In this role, he advised on a variety of corporate matters, including representing a pharmaceutical company in the acquisition of numerous product portfolios in dozens of countries worldwide. He also acted as underwriters' counsel for numerous offerings of debt and equity securities.